Lexaria Bioscience Corp. (LEXX)
0.7368
-0.02
(-2.90%)
USD |
NASDAQ |
Jan 20, 11:33
Lexaria Bioscience Shareholders Equity (Quarterly): 4.913M for Nov. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 0.0827M |
| Aurinia Pharmaceuticals, Inc. | 365.77M |
| Edesa Biotech, Inc. | 12.45M |
| Xenon Pharmaceuticals, Inc. | 559.51M |
| ProMIS Neurosciences, Inc. | 9.187M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.051M |
| Total Liabilities (Quarterly) | 1.527M |
| Debt to Equity Ratio | 0.0207 |
| Current Ratio | 3.682 |
| Net Debt Paydown Yield | 0.03% |